Related references
Note: Only part of the references are listed.Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck
Susumu Okano et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Youn-Sang Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Long Non-Coding RNA DLEUI Up-Regulates BIRC6 Expression by Competitively Sponging miR-381-3p to Promote Cisplatin Resistance in Nasopharyngeal Carcinoma
Hangbo Li et al.
ONCOTARGETS AND THERAPY (2020)
Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study
Xu-Shan Sun et al.
LANCET ONCOLOGY (2020)
Head and neck squamous cell carcinoma
Daniel E. Johnson et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Head and Neck Cancer
Laura Q. M. Chow
NEW ENGLAND JOURNAL OF MEDICINE (2020)
WNT974 Inhibits Proliferation, Induces Apoptosis, and Enhances Chemosensitivity to Doxorubicin in Lymphoma Cells by Inhibiting Wnt/β-Catenin Signaling
Senmin Chen et al.
MEDICAL SCIENCE MONITOR (2020)
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway
Zejia Yang et al.
BMC CANCER (2019)
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II Study
Dean A. Fennell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications
Claudia Peitzsch et al.
CANCERS (2019)
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Shang-Hung Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy
Carlos J. Diaz Osterman et al.
ELIFE (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
A view on drug resistance in cancer
Neil Vasan et al.
NATURE (2019)
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer
Hyung Kwon Byeon et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
Souvick Roy et al.
CELLULAR ONCOLOGY (2018)
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
Robert L. Ferris et al.
ORAL ONCOLOGY (2018)
Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer
Hui-Ming Lin et al.
PROSTATE (2018)
Apoptosis-sensitizing activity of birinapant in head and neck squamous cell carcinoma cell lines
Roman C. Brands et al.
ONCOLOGY LETTERS (2018)
Nuclear FAK and its kinase activity regulate VEGFR2 transcription in angiogenesis of adult mice
Shaogang Sun et al.
SCIENTIFIC REPORTS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
DNA repair pathways and cisplatin resistance: an intimate relationship
Clarissa Ribeiro Reily Rocha et al.
CLINICS (2018)
DEBIO 1143, an IAP inhibitor, reverses carboplatin resistance in ovarian cancer cells and triggers apoptotic or necroptotic cell death
Benoit Thibault et al.
SCIENTIFIC REPORTS (2018)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 100 randomized trials and 19,248 patients, on behalf of MACH-NC group
P. Blanchard et al.
ANNALS OF ONCOLOGY (2017)
High-level III-tubulin overexpression occurs in most head and neck cancers but is unrelated to clinical outcome
Julie C. Nienstedt et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2017)
Livin enhances chemoresistance in head and neck squamous cell carcinoma
Tae Mi Yoon et al.
ONCOLOGY REPORTS (2017)
A New View of Pathway-Driven Drug Resistance in Tumor Proliferation
Ruth Nussinov et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer
Chun-mei Kuang et al.
CELL DEATH & DISEASE (2017)
The FOXM1-ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Youxiang Hou et al.
CELL DEATH & DISEASE (2017)
RSF1 regulates the proliferation and paclitaxel resistance via modulating NF-KB signaling pathway in nasopharyngeal carcinoma
Yong Liu et al.
JOURNAL OF CANCER (2017)
Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma
Linda Tran et al.
CANCER IMMUNOLOGY RESEARCH (2017)
TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition
Sai-Lan Liu et al.
CANCER LETTERS (2017)
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
Rama Rathore et al.
APOPTOSIS (2017)
Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line
Xiaoli Shi et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy (Publication with Expression of Concern. See vol. 5, 2021) (Publication with Expression of Concern. See vol. 2, 2018)
V. La et al.
NPJ PRECISION ONCOLOGY (2017)
Expression and clinical significance of Apollon in esophageal squamous cell carcinoma
Rong Li et al.
MOLECULAR MEDICINE REPORTS (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Overexpression of beta-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
Long Li et al.
BIOMED RESEARCH INTERNATIONAL (2016)
5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers
Lauren Van der Kraak et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
A fate worse than death: apoptosis as an oncogenic process
Gabriel Ichim et al.
NATURE REVIEWS CANCER (2016)
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Jin Peng et al.
CANCER RESEARCH (2015)
Inhibition of the ERCC1-XPF structure-specific endonuclease to overcome cancer chemoresistance
Ewan M. McNeil et al.
DNA REPAIR (2015)
Establishment and characterization of triple drug resistant head and neck squamous cell carcinoma cell lines
Sindhu Valiyaveedan Govindan et al.
MOLECULAR MEDICINE REPORTS (2015)
ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: A meta-analysis
Ma Xuelei et al.
ORAL ONCOLOGY (2015)
EGFR and NF-κB: partners in cancer
Kateryna Shostak et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck
Min Yao et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
C. H. Chung et al.
ANNALS OF ONCOLOGY (2014)
Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4
Sang Hyuk Lee et al.
JOURNAL OF PATHOLOGY (2014)
Head and Neck Cancers, Version 2.2014
David G. Pfister et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)
Association of Drug Transporter Expression with Mortality and Progression-Free Survival in Stage IV Head and Neck Squamous Cell Carcinoma
Rolf Warta et al.
PLOS ONE (2014)
Systems biology of cisplatin resistance: past, present and future
L. Galluzzi et al.
CELL DEATH & DISEASE (2014)
FAK in cancer: mechanistic findings and clinical applications
Florian J. Sulzmaier et al.
NATURE REVIEWS CANCER (2014)
Phase II study of sorafenib in combination with cisplatin and 5-fluorouracil to treat recurrent or metastatic nasopharyngeal carcinoma
C. Xue et al.
ANNALS OF ONCOLOGY (2013)
Inhibition of Wnt/β-catenin signaling downregulates P-glycoprotein and reverses multi-drug resistance of cholangiocarcinoma
Dong-Yan Shen et al.
CANCER SCIENCE (2013)
ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression
Taku Kato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
A Phase 2 Study of Bevacizumab With Cisplatin Plus Intensity-Modulated Radiation Therapy for Stage III/IVB Head and Neck Squamous Cell Cancer
Matthew G. Fury et al.
CANCER (2012)
FoxM1 and Wnt/β-Catenin Signaling in Glioma Stem Cells
Aihua Gong et al.
CANCER RESEARCH (2012)
All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway
Young Chang Lim et al.
EUROPEAN JOURNAL OF CANCER (2012)
The expression and significance of MRP1, LRP, TOPOIIß, and BCL2 in tongue squamous cell carcinoma
Bin Zhang et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2012)
Targeting IAP proteins for therapeutic intervention in cancer
Simone Fulda et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Molecular mechanisms of cisplatin resistance
L. Galluzzi et al.
ONCOGENE (2012)
XIAP Is a Predictor of Cisplatin-Based Chemotherapy Response and Prognosis for Patients with Advanced Head and Neck Cancer
Xi-Hu Yang et al.
PLOS ONE (2012)
Multimodality Molecular Imaging of Apoptosis in Oncology
Francis G. Blankenberg et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2011)
Overexpression of cIAP2 contributes to 5-FU resistance and a poor prognosis in oral squamous cell carcinoma
M. Nagata et al.
BRITISH JOURNAL OF CANCER (2011)
High ERCC1 expression predicts cisplatin-based chemotherapy resistance and poor outcome in unresectable squamous cell carcinoma of head and neck in a betel-chewing area
Tai-Jan Chiu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas
Young Chang Lim et al.
ORAL ONCOLOGY (2011)
Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel
Z. Khan et al.
CURRENT CANCER DRUG TARGETS (2010)
Targeting focal adhesion kinase signaling in tumor growth and metastasis
Joerg Schwock et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Focal Adhesion Kinase and p53 signal transduction pathways in cancer
Vita M. Golubovskaya et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2010)
Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity
Anutosh Ganguly et al.
MOLECULAR CANCER THERAPEUTICS (2010)
ABC transporters in cancer: more than just drug efflux pumps
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2010)
Participation of DNA repair in the response to 5-fluorouracil
M. D. Wyatt et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Mechanisms of tumor resistance to EGFR-targeted therapies
Elizabeth A. Hopper-Borge et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
DETECTION OF SURVIVIN AND p53 IN HUMAN ORAL CANCER: CORRELATION WITH CLINICOPATHOLOGIC FINDINGS
Zakir Khan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2009)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation
H. J. Jun et al.
BRITISH JOURNAL OF CANCER (2008)
Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2008)
Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied
Daniela A. Brito et al.
JOURNAL OF CELL BIOLOGY (2008)
Cancer stem cells in head and neck squamous cell cancer
Mark E. P. Prince et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
5-fluorouracil: Mechanisms of resistance and reversal strategies
Ning Zhang et al.
MOLECULES (2008)
Platinum-based chemotherapy plus cetuximab in head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
Increased mitochondrial DNA induces acquired docetaxel resistance in head and neck cancer cells
T. Mizumachi et al.
ONCOGENE (2008)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R. Posner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
M. E. Prince et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The roles of copper transporters in cisplatin resistance
Macus Tien Kuo et al.
CANCER AND METASTASIS REVIEWS (2007)
Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
Scott Wilhelm et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number
Marta Canel et al.
CLINICAL CANCER RESEARCH (2006)
Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer
R Hitt et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study
B Burtness et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Nuclear expression of cIAP-1, an apoptosis inhibiting protein, predicts lymph node metastasis and poor patient prognosis in head and neck squamous cell carcinomas
T Tanimoto et al.
CANCER LETTERS (2005)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
βIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability
K Kamath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Microtubules as a target for anticancer drugs
MA Jordan et al.
NATURE REVIEWS CANCER (2004)
The spindle checkpoint, aneuploidy, and cancer
R Bharadwaj et al.
ONCOGENE (2004)
Pathways of apoptotic and non-apoptotic death in tumour cells
H Okada et al.
NATURE REVIEWS CANCER (2004)
Bevacizumab
M Muhsin et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
The role of copper transporters in the development of resistance to Pt drugs
R Safaei et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2004)
Mechanisms of Taxol resistance related to microtubules
GA Orr et al.
ONCOGENE (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation
R. Z. Yusuf et al.
CURRENT CANCER DRUG TARGETS (2003)
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
S Ishida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Induction chemotherapy with paclitaxel, cisplatin and 5-fluorouracil for squamous cell carcinoma of the head and neck:: long-term results of a phase II trial
R Hitt et al.
ANNALS OF ONCOLOGY (2002)
IAP proteins: Blocking the road to death's door
GS Salvesen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Share Paper
